Company: BIAF
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001641172-25-001840
Chunk: 1318

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 15
Chunk 1318
---
     
    March
    31, 2025
  
    Stuart
    Diamond

    /s/
    Peter S. Knight
     
    Director
     
    March
    31, 2025
  
    Peter
    S. Knight

    /s/
    Gary Rubin 
     
    Director
     
    March
    31, 2025
  
    Gary
    Rubin

    /s/
    Roby Joyce, M.D.
     
    Director
     
    March
    31, 2025
  
    Roby
    Joyce

    /s/
    Jamie Platt
     
    Director
     
    March
    31, 2025
  
    Jamie
    Platt

 70 

bioAffinity
Technologies, Inc.

Index
to the Consolidated Financial Statements

    Report of Independent Registered Public Accounting Firm (PCAOB ID NO. 100)
    F-2

    Consolidated Balance Sheets as of December 31, 2024 and 2023
    F-3

    Consolidated Statements of Operations for the years ended December 31, 2024 and 2023
    F-4

    Consolidated Statements of Changes in Convertible Preferred Stock and Stockholders’ Equity for the years ended December 31, 2024 and 2023
    F-5

    Consolidated Statements of Cash Flows for the years ended December 31, 2024 and 2023
    F-6

    Notes to Consolidated Financial Statements
    F-7

F-1

Report
of Independent Registered Public Accounting Firm

To
the Board of Directors and Stockholders of

bioAffinity
Technologies, Inc.:

Opinion
on the Consolidated Financial Statements

We
have audited the accompanying consolidated balance sheets of bioAffinity Technologies, Inc. (the “Company”) as of
December 31, 2024 and 2023, and the related consolidated statements of operations, changes in stockholders’ equity, and cash
flows, for each of the two years in the period ended December 31, 2024, and the related notes (collectively referred to as the
“consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all
material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results
of